Related Experiment Video
Updated: Dec 30, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Handling hearsay in diabetes care
Sanjay Kalra1, Hitesh Punyani2
1Department of Endocrinology, Bharti Hospital, Karnal, India.
Hearsay and misinformation impede diabetes management. This communication outlines the drawbacks of hearsay and offers strategies for physicians to address it in patients and communities.
Area of Science:
- Medical Practice
- Public Health
- Health Communication
Background:
- Hearsay, including electronic hearsay (e-hearsay), is prevalent in contemporary healthcare.
- Misinformation poses significant challenges to patient acceptance and adherence to diabetes management plans.
- Technological advancements have accelerated the dissemination of both accurate information and misinformation.
Purpose of the Study:
- To elucidate the detrimental effects of hearsay in medical contexts.
- To provide actionable strategies for healthcare professionals to combat diabetes-related misinformation.
- To enhance patient understanding and engagement in diabetes self-management.
Main Methods:
- This communication is a review and synthesis of current understanding regarding hearsay in medicine.
- It analyzes the impact of misinformation on diabetes care.
- It proposes practical approaches for physicians to address patient concerns stemming from hearsay.
Main Results:
- Hearsay creates barriers to effective diabetes management and patient adherence.
- The digital age amplifies the spread of health-related misinformation.
- Physicians require specific communication skills to counteract hearsay.
Conclusions:
- Addressing hearsay is crucial for improving diabetes outcomes.
- Healthcare providers must actively engage with patients to correct misinformation.
- Community-level interventions may be necessary to combat widespread health myths.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
10:32Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
Published on: January 11, 2013
Related Concept Videos
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Ethical Standards II
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Legal Guidelines for Documentation